151 related articles for article (PubMed ID: 2868766)
1. Acute schizophrenia.
Johnstone EC
Br J Hosp Med; 1985 Oct; 34(4):198-201. PubMed ID: 2868766
[TBL] [Abstract][Full Text] [Related]
2. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
Faraone SV; Brown WA; Laughren TP
J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and neuroleptic drugs.
Green AI; Brown WA
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):213-23. PubMed ID: 2897910
[TBL] [Abstract][Full Text] [Related]
4. The natural course of schizophrenia and effective maintenance drug treatment.
Davis JM; Andriukaitis S
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):2S-10S. PubMed ID: 2870087
[TBL] [Abstract][Full Text] [Related]
5. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
[No Abstract] [Full Text] [Related]
6. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
7. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-refractory patients and their drug plasma levels.
Berrios GE
Encephale; 1982; 8(4):465-85. PubMed ID: 6129961
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic features and effects of neuroleptics.
Seeman MV
Can Med Assoc J; 1981 Oct; 125(8):821-6. PubMed ID: 6118205
[TBL] [Abstract][Full Text] [Related]
10. [Flupenthixol--a partial atypical neuroleptic?].
Kühn KU; Meyer K; Maier W
Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
[TBL] [Abstract][Full Text] [Related]
11. [Initial clinical response to neuroleptic treatment and serum prolactin levels in acute schizophrenic psychoses].
Fuentenebro de Diego F; Cabranes JA; Ramos Brieva J; López Jiménez MR; Santiesteban Requena C
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1981; 9(6):499-506. PubMed ID: 6129779
[No Abstract] [Full Text] [Related]
12. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
13. [Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
Vanelle JM; Amorim P; Piketti ML; Bourdel MC; Poirier-Littré MF
Encephale; 1996 Oct; 22 Spec No 3():82-4. PubMed ID: 8954284
[No Abstract] [Full Text] [Related]
14. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
Hogarty GE
J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride: a review of its efficacy in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
17. Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
Pandina GJ; Canuso CM; Youssef E; Kujawa M; Mahmoud R
Hum Psychopharmacol; 2007 Jul; 22(5):326-7; author reply 328. PubMed ID: 17599334
[No Abstract] [Full Text] [Related]
18. [Modification of long-term schizophrenia by somato-therapeutic measures].
Gross G; Huber G; Schüttler R
Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
[TBL] [Abstract][Full Text] [Related]
19. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
[TBL] [Abstract][Full Text] [Related]
20. Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Hamner MB; Arvanitis LA; Miller BG; Link CG; Hong WW
Psychopharmacol Bull; 1996; 32(1):107-10. PubMed ID: 8927658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
